| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.36 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |